|
|
Volumn 302, Issue 5645, 2003, Pages 594-596
|
|
Race and Medicine
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUCINDOLOL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
NEUROLEPTIC AGENT;
ROSUVASTATIN;
BLOOD SAMPLING;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CORRELATION ANALYSIS;
DISEASE COURSE;
DRUG DOSE REGIMEN;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG TARGETING;
ENVIRONMENTAL FACTOR;
GENE FREQUENCY;
GENETIC ANALYSIS;
GENETIC VARIABILITY;
GENOTYPE;
HEART FAILURE;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
INDIAN;
MEDICAL DECISION MAKING;
NOTE;
OBESITY;
POPULATION GENETICS;
PRIORITY JOURNAL;
RACE;
RACE DIFFERENCE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADRENERGIC BETA-ANTAGONISTS;
AFRICAN CONTINENTAL ANCESTRY GROUP;
ANTICHOLESTEREMIC AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
CONTINENTAL POPULATION GROUPS;
ETHNIC GROUPS;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
HYPERTENSION;
INDIA;
PHARMACEUTICAL PREPARATIONS;
PHARMACOGENETICS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
RISK FACTORS;
VARIATION (GENETICS);
|
|
EID: 0142209382
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.302.5645.594 Document Type: Note |
|
Times cited : (51)
|
|
References (0)
|